Taiho Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Taiho Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Taiho Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Taiho Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Taiho Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390251A1 | Application | Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inhibitor | A61K31/4245; A61K45/06; A61P35/02 | December 07, 2023 |
| EP4284378A1 | Application | Krebsbehandlung bei patienten mit pten-inaktivierender mutation | A61K31/5365; A61P35/00; C07D498/14 | December 06, 2023 |
| US11833151B2 | Grant | Pharmaceutical composition including sodium alkyl sulfate | A61K31/519; A61K47/12; A61K47/20; A61K47/26; A61K47/38; A61K9/0095; A61K9/14; A61K9/48 | December 05, 2023 |
| PL3533449T3 | Grant | Selective inhibitor of exon 20 insertion mutant egfr | A61K31/519; A61P35/00 | November 20, 2023 |
| JP7379680B2 | Grant | テルフェニル化合物の新規な塩 | A61K2300/00; A61K31/203; A61K31/40; A61P35/00; A61P35/02; C07B2200/13; C07C63/08; C07D207/14 | November 14, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer